Gilead Sciences (GILD) PT Lowered to $168 at Morgan Stanley

May 11, 2026 8:27 AM

Morgan Stanley analyst Terence Flynn lowered the price target on Gilead Sciences (NASDAQ: GILD) to $168.00 (from $175.00) while maintaining a Overweight rating.

No results found